Futura Medical (LON:FUM) Shares Up 10.3% – What’s Next?

Futura Medical plc (LON:FUM)’s share price shot up 10.3% during mid-day trading on Friday . The stock traded as high as GBX 0.42 and last traded at GBX 0.42. Approximately 3,594,404 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 9,689,350 shares. The stock had previously closed at GBX 0.38.

Futura Medical Price Performance

The firm’s 50 day moving average is GBX 0.52 and its 200 day moving average is GBX 0.93. The company has a market capitalization of £2.43 million, a PE ratio of -0.15 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The firm had revenue of GBX 170 million for the quarter. As a group, analysts predict that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.